StockMarketWire.com - ConvaTec Group has expanded its manufacturing technology platform for the insulin pump therapy business at Medtronic.

ConvaTec said that with this expansion its Unomedical subsidiary was increasing its production capabilities to sustain the range of infusion sets and insulin pump therapy solutions offered by the Diabetes Group at Medtronic.

ConvaTec said the arrangement further deepened the companies' long-standing partnership within diabetes care and their shared commitment to meeting the growing demand for insulin pump therapy among people with diabetes.


At 9:19am: [LON:CTEC] ConvaTec Group Plc share price was +0.9p at 273.9p



Story provided by StockMarketWire.com